The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis
Completed · Phase 3
Conditions studied: Candidiasis
In brief
Anidulafungin is a medicine being developed for treatment of patients with certain kinds of fungal infections. These infections due to yeast (a type of fungus) in the mouth/esophagus, in the blood or in other areas within the body.
Key facts
- Study ID
- NCT00056368
- Run by
- Pfizer
- People needed
- 256
- Starts
- 2003-03-01
- Expected to finish
- 2004-10-01
- Last updated by the study team
- 2008-10-21
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Versicor, Inc. — King of Prussia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.